-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GM-6 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GM-6 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GM-6 in Parkinson's Disease Drug Details: GM-6 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GM-2505 in Psychiatric Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GM-2505 in Psychiatric Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GM-2505 in Psychiatric Disorders Drug Details: GM-2505 is under development for...
-
Product Insights
GM Sugars Cogeneration Power Plant
GM Sugars Cogeneration Power Plant is a biopower project located in Karnataka, India. The project is owned and being developed by GM Sugars and Energy Ltd. The project is at the permitting stage. Empower your strategies with our GM Sugars Cogeneration Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GM-2505 in Depression
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GM-2505 in Depression Drug Details: GM-2505 is under development for the treatment of depression and...
-
Thematic Analysis
NewRobotics in Automotive – Thematic Intelligence
Robotics in Automotive Thematic Report Overview Robotics has significantly impacted the automotive sector by revolutionizing production processes and enhancing efficiency. Integrating robotics in automotive manufacturing has increased precision, reduced human error, and improved safety conditions. Manufacturers also believe automation to be the fastest way to improve productivity. Furthermore, the advent of autonomous vehicles (AVs) has deepened the role of robotics in the sector, requiring sophisticated artificial intelligence (AI) technologies for navigation and decision-making. The ‘Robotics in Automotive’ thematic intelligence report...
-
Company Insights
Innovation and Patenting activity of GMS Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of GMS Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trabikibart in Allergic Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabikibart in Allergic Asthma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabikibart in Allergic Asthma Drug Details: CSL-311 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GM-1020 in Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GM-1020 in Depression report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GM-1020 in Depression Drug Details: GM-1020 is under development for the treatment of depression...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dinutuximab in Osteosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dinutuximab in Osteosarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dinutuximab in Osteosarcoma Drug Details: Dinutuximab (Unituxin) is a chimeric monoclonal antibody, composed...